S-ICD as a first-line therapy: Results from the PRAETORIAN & UNTOUCHED Trials
November 5, 2020
Join to hear Dr. Ulrika Birgersdotter-Green, Dr. Reinoud Knops, and Dr. Michael Gold discuss the results from the PRAETORIAN & UNTOUCHED trials.
___________________________
Video Index:
0:00 - 2:52 Part 1 of 4: Dr. Ulrika Birgersdotter-Green introduces the product workshop
2:53 - 23:47 Part 2 of 4: Dr. Reinoud Knops talks about the results from the PRAETORIAN trial, first prospective randomized head-to-head trial comparing the performance of S-ICD and TV-ICD
23:47 - 42:46 Part 3 of 4: Dr. Gold talks about the results from the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low Ejection Fraction (UNTOUCHED) study
42.46 - 1:01:22 Part 4 of 4: Dr. Ulrika Birgersdotter-Green, Dr. Reinoud Knops and Dr. Michael Gold discuss the results from the PRAETORIAN & UNTOUCHED trials
___________________________
Video Index:
0:00 - 2:52 Part 1 of 4: Dr. Ulrika Birgersdotter-Green introduces the product workshop
2:53 - 23:47 Part 2 of 4: Dr. Reinoud Knops talks about the results from the PRAETORIAN trial, first prospective randomized head-to-head trial comparing the performance of S-ICD and TV-ICD
23:47 - 42:46 Part 3 of 4: Dr. Gold talks about the results from the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low Ejection Fraction (UNTOUCHED) study
42.46 - 1:01:22 Part 4 of 4: Dr. Ulrika Birgersdotter-Green, Dr. Reinoud Knops and Dr. Michael Gold discuss the results from the PRAETORIAN & UNTOUCHED trials
Login to view comments.
Click here to Login
Product Workshop S-ICD as a first-line therapy: Results from the PRAETORIAN & UNTOUCHED Trials
Thumbs Up
- November 5, 2020
- 1
